# Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients

> **NCT01061320** · PHASE3 · UNKNOWN · sponsor: **Thammasat University** · enrollment: 200 (estimated)

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **DRUG:** alpha tocopherol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01061320
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061320, "Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01061320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*